Northwestern Medicine - Urology
Chicago, Illinois 60611
0 studies enrolling now · 2 studies all time
What they study most
Biochemically Recurrent Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer
Studies at this site
- A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
- A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. — Running, not enrolling